AzTrials
AzTrials

Tooth DiscolorationNCT03217994

Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent

A study testing gel HP in people with Tooth Discoloration, run by University of Chile at 1 site in Chile.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study investigates whether it is possible to achieve equally satisfactory results between 37.5% hydrogen peroxide gel and 6% gel for teeth bleaching. A prospective, double-blind, randomized clinical trial was carried out. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Tooth Discoloration
What is being tested?
gel HP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteChile
Study dates
1 Jan 2015to 31 Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age over 18 years (both sexes)
  • 6 present upper front teeth
  • No caries
  • No restorations (anterosuperior group)
  • No previous whitening treatments
  • Tooth color value of A3 or less (Vita Classical scale), which was determined with a spectrophotometer (Vita Easy Shade® Compact) on the middle third of the vestibular surface of the maxillary lateral incisors

Who cannot join

  • Pregnant or nursing mothers
  • In pharmacological treatment
  • Bruxism and patients who reported prior tooth sensitivity
  • Previous tooth whitening (either at home or professionally)
  • Visible dental cracks, developmental defects or teeth stained by tetracycline or fluorosis in the anterosuperior group
  • Treatment with fixed appliances
  • Periodontal disease or cancer

Trial locations and contacts

1 site in 1 country.

Chile1 site
  • Eduardo Fernandez

    Santiago, N/A = Not Applicable, 7500505

Other trials in Chile

About this study

Official title: Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent Without Ligth

The present study investigates whether it is possible to achieve equally satisfactory results between 37.5% hydrogen peroxide gel and 6% gel for teeth bleaching. A prospective, double-blind, randomized clinical trial was carried out. A total of 33 patients were selected from the clinic of the Faculty of Dentistry at the University of Chile. The patients included men and women over 18 years old without prior tooth whitening treatments, tooth decay, or restorations of the upper front teeth. The patients had tooth colors of A3 or less according to the Vita Classical scale, which was determined with a Vita Easy® Shade spectrophotometer. The study was carried out with a "split-mouth" design. One side of each mouth was randomly treated with 37.5% hydrogen peroxide, and the other side was bleached with 6% hydrogen peroxide. Each group received 3 to 12 minutes of treatment with the respective gel applications. Two sessions of bleaching were carried out each week. Color was assessed at 7 different sessions for 3 months. The spectrophotometer was used to measure the total variation of color (ΔE) between the baseline (session 1) and different measurement times (sessions 2-7). We compared ΔE for both agents using the Mann-Whitney test.

Read the detailed description
  1. Materials and methods

2.1. Study design This study was a double-blind, randomized, prospective clinical trial. The study was conducted according to the recommendations of CONSORT (Consolidated Standards of Reporting Trials) while following the principles of the Helsinki Convention.

2.2. Description of the sample 2.2.1. Selection of the sample

A total of 33 patients were selected from the clinic of the Faculty of Dentistry at the University of Chile. The patients had been seeking whitening treatment and volunteered to participate in the study. The selected patients had to meet all the inclusion criteria and signed informed consent forms (appendix 1) adopted by the Ethics Committee of Faculty of Dentistry. The inclusion criteria were the following:

  • Age over 18 years (both sexes)
  • 6 present upper front teeth
  • No caries
  • No restorations (anterosuperior group)
  • No previous whitening treatments
  • Tooth color value of A3 or less (Vita Classical scale), which was determined with a spectrophotometer (Vita Easy Shade® Compact) on the middle third of the vestibular surface of the maxillary lateral incisors

Patients were excluded based on the following criteria:

  • Pregnant or nursing mothers
  • In pharmacological treatment
  • Bruxopatas and patients who reported prior tooth sensitivity
  • Previous tooth whitening (either at home or professionally)
  • Visible dental cracks, developmental defects (hypoplasias enamel, hipomineralizaciones, etc.), or teeth stained by tetracycline or fluorosis in the anterosuperior group
  • Treatment with fixed appliances
  • Periodontal disease or cancer
  • Presence of non-carious cervical lesions, or endodontics in the anterosuperior group

Patients who experienced any pathologies that prevented them from entering the study (such as caries, periodontal disease, or dental sensitivity) were directed for treatment to the dental clinic of the Faculty of Dentistry of the University of Chile.

2.2.2. Sample size The sample size n was determined based on similar previous studies (Bortolatto et al., 2014; Martin et al., 2015; Fernandez et al., 2016). A minimum n of 25 patients per group was determined. A significance level of 5% was considered at (1-β) 0.80 with a drop-out rate of 5%.

2.2.3. Study location Treatments were carried out at the clinic of the Faculty of Dentistry of the University of Chile. During this period, volunteers were supervised by the researchers.

2.3. Procedure 2.3.1. Determination of study groups The study was carried out with a "split-mouth" design. Bleaching agents (hydrogen peroxide) were randomly assigned to each hemiarcade. The operators (R.H. and M.P.) were unaware of the product being used. To achieve this, automixed syringes from a Polaoffice+ whitening kit were used (SDI Limited, Bayswater, Australia). The syringes contained hydrogen peroxide in the form of thixotropic gel at a concentration determined by the manufacturer and marked properly.

Each gel syringe was re-labeled with a key number depending on the concentration of the agent, which was determined by an operator (G.Z.) who was unaware of the procedures. All color measurements were performed on the upper lateral incisors by different operators from those mentioned (C.A. and C.A.). In one group, the hemiarcade was bleached with 37.5% hydrogen peroxide (Polaoffice + 37.5% SDI Limited, Bayswater, Australia). In the other group, the hemiarcade was bleached using 6% hydrogen peroxide (Polaoffice + 6% SDI Limited, Bayswater, Australia).

2.3.2. Preliminary phase We first verbally explained the procedures to perform and asked each volunteer to read and sign an informed consent form (appendix 1). A clinic card (appendix 2) was completed for each patient. In each case, a heavy silicone matrix (Speedex® Putty) was prepared for both maxillary lateral incisors. These matrices were drilled at the height of the union of the cervical third with the middle third of the vestibular tooth face to standardize the color measurements with the spectrophotometer (Vita Zahnfabrik, Bad Säckingen, Germany). Another reason was to create a perfect fit with the nozzle of the spectrophotometer to help control the passage of light to the measurement site. The color of each upper lateral incisor was measured using the spectrophotometer, which was previously calibrated according to the manufacturer's instructions using arrays of heavy silicone.

2.3.3. Bleaching protocol Two whitening sessions were carried out with intervals of one week. At the beginning of each session, dental prophylaxis was done with a brush at low speed. Stone pumice and water were used in the upper front to remove the layer from the surface of the teeth enamel so that it would not alter the effectiveness of the gels. We used a plastic lip separator, a blue gingival barrier syringe, and light-curing (Polaoffice + SDI Limited, Bayswater, Australia) to protect the soft tissue. We homogeneously applied the different gels on the vestibular surfaces of each hemiarcade. One hemiarcade was treated with 37.5% hydrogen peroxide, and the other was treated with 6% hydrogen peroxide (Polaoffice + SDI Limited, Bayswater, Australia).

The protocol included 3 applications of 12 minutes each. The gels were in full contact with the tooth surface and then were removed between each application with cotton rolls, which were moistened with water and dried carefully. At the end of the third application, we removed the gels, washed off all excess with plenty of water, and removed the gingival barrier.

2.3.4. After bleaching All patients were instructed to avoid consuming foods with a high content of pigments, such as coffee, tea, wine, and beets during the study period.

2.3.5. Controls At the end of the first session, we measured the color of each lateral incisor with the calibrated spectrophotometer. A week later, the same protocol was repeated. The time to control sessions was considered from the last session of whitening.

Figure 3: Measurement times.

2.3.6. Tabulation of data

Data obtained in each period were tabulated according to the three axes of the CIELAB system (L *, a *, and b *). We also calculated ΔE using the Pythagorean theorem as follows (Westland et al., 2003):

ΔE = [(ΔL)2 + (Δa)2 + (Δb)2]1/2

The variation of each parameter in different times was always calculated in relation to the initial values (the color measurement prior to the first session of whitening).

Being tested
gel HP
Medical subject headings
Tooth Discoloration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gel HPDrug

    gel of hygrogen peroxide for teeth bleaching

Study groups in NCT03217994
Study groupRoleWhat they receive
37.5% gelActive comparator37.5% gel to bleach teeth
Receives: Drug: gel HP
6% gelExperimental6% gel to bleach teeth
Receives: Drug: gel HP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efectiveness by color difference ( using the spectrophotometer Vita Easy Shade)

    The shade was determined using the obtained parameters L*, a*, and b* by Spectrophotometer . The color alteration after each session was given by the differences between the values obtained at the session and the baseline (∆E). ∆E was calculated using the following formula: ΔE = [(ΔL*)2 + (Δa*)2 + (Δb*)2]1/2 .

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2017
  2. Study start1 Jan 2015
  3. Primary completion31 Dec 2016
  4. Study completion31 Dec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03217994
Sponsor's protocol ID
15/001b
Status last verified
Jul 2017
First submitted
12 Jul 2017
Last updated
14 Jul 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Estay J, Angel P, Bersezio C, Tonetto M, Jorquera G, Pena M, Fernandez E. The change of teeth color, whiteness variations and its psychosocial and self-perception effects when using low vs. high concentration bleaching gels: a one-year follow-up. BMC Oral Health. 2020 Sep 11;20(1):255. doi: 10.1186/s12903-020-01244-x.

    PubMed 32917192

Questions about this trial

What is this clinical trial studying?

A study testing gel HP in people with Tooth Discoloration, run by University of Chile at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efectiveness by color difference ( using the spectrophotometer Vita Easy Shade) (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03217994, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in